VTGN - VistaGen Therapeutics GAAP EPS of -$0.66 beats by $0.02 revenue of $0.28M
2023-11-09 17:07:10 ET
More on VistaGen Therapeutics
- Vistagen Therapeutics, Inc. (VTGN) Q1 2024 Earnings Call Transcript
- Vistagen prices $100M underwritten offering
- Vistagen in pact to issue a potential license for hot flashes therapy in Japan
- Seeking Alpha’s Quant Rating on VistaGen Therapeutics
- Historical earnings data for VistaGen Therapeutics
For further details see:
VistaGen Therapeutics GAAP EPS of -$0.66 beats by $0.02, revenue of $0.28M